Pfizer and Allergan have announced their much-anticipated merger, agreeing a $160bn deal that will be the world's third biggest corporate deal ever, after AOL/Time Warner and Vodafone/Mannesmann. The deal is by far the biggest healthcare transaction in history; the previous largest was also completed by Pfizer (when it bought Warner-Lambert for $90bn 15 years ago).
Pfizer, Allergan In Third-Biggest Merger Ever
Pfizer and Allergan have announced their much-anticipated merger, agreeing a $160bn deal that will be the world's third biggest corporate deal ever, after AOL/Time Warner and Vodafone/Mannesmann. The deal is by far the biggest healthcare transaction in history; the previous largest was also completed by Pfizer (when it bought Warner-Lambert for $90bn 15 years ago).
More from Business
More from Scrip
• By
BridgeBio reported $36.7m in Q1 2025 sales of its ATTR-CM drug Attruby, tripling consensus forecasts. Vyndaquel-maker Pfizer acknowledged the product’s impact during the quarter.
• By
The San Diego biotech’s lead product candidate is an antisense oligonucleotide-based therapy slated to enter Phase III development in the third quarter.
• By
The company’s FcRn inhibitor nipocalimab was approved by the US FDA for generalized myasthenia gravis (gMG), where it will join a competitive market.